Admission to Main Market

Source: RNS
RNS Number : 0760P
Elixirr International PLC
01 July 2025
 

This announcement is an advertisement for the purposes of the Prospectus Regulation Rules of the Financial Conduct Authority and not a prospectus. This announcement does not constitute or form part of, and should not be construed as, an offer for sale or subscription of, or solicitation of any offer to subscribe for or to acquire, any ordinary shares of Elixirr International plc in any jurisdiction, including in or into or from the United States of America, Australia, Canada, Japan, the Republic of South Africa or in any other jurisdiction.

1 July 2025

ELIXIRR INTERNATIONAL PLC

Admission to trading on the Main Market of the London Stock Exchange
 and
Cancellation of admission to trading on AIM

Further to the announcement on 24 June 2025, Elixirr International plc (AIM:ELIX) ("Elixirr", the "Company" or, together with its subsidiary undertakings, the "Group"), an established, global award-winning challenger consultancy, is pleased to announce that its ordinary shares (the "Ordinary Shares") will be admitted to listing on the Equity Shares (Commercial Companies) Category of the Official List of the Financial Conduct Authority and to trading on the Main Market for listed securities of the London Stock Exchange (together, "Admission") at 8.00 a.m. today and, accordingly, will be cancelled from trading on AIM.

 

Elixirr is not offering any new Ordinary Shares nor any other securities in connection with Admission. Following Admission, the Ordinary Shares will continue to be registered with their existing ISIN of GB00BLPHTX84 and the TDIM will remain ELIX.

 

The Company's shareholders should consult their own professional advisers regarding the consequences of Admission for them.

 

Stephen Newton, Founder and CEO of Elixirr, commented:

 

"Since our IPO in 2020, we've delivered consistent growth, expanded our global footprint, and strengthened our position as the Challenger Consultancy. This move reflects our continued ambition to scale the business, access a broader investor base, and reinforce our long-term commitment to building the best consultancy in the world. I'm immensely proud of what we've achieved so far and excited for what lies ahead."

 

 

Enquiries:

 

For enquiries, please refer to the Company's Investor Contacts page:

https://www.elixirr.com/investors/investor-contacts

Elixirr International plc                                                                                    +44 (0)20 7220 5410  

Stephen Newton, Chief Executive Officer

Graham Busby, Deputy Chief Executive Officer

Nick Willott, Chief Financial Officer and Company Secretary

investor-relations@elixirr.com

Cavendish Capital Markets Ltd (Joint Broker)          +44 (0)20 7220 0500

Stephen Keys, Callum Davidson, Isaac Hooper (Corporate Finance),

Sunila De Silva (ECM)

Peel Hunt LLP (Sponsor & Joint Broker)                                                     +44 (0)20 7418 8900             

Neil Patel, Ben Cryer, Alice Lane, Kate Bannatyne

 

About Elixirr International plc

Elixirr is an award-winning global consulting firm working with clients across a diverse range of industries, markets and geographies. Founded in 2009, the firm set out to be the 'challenger consultancy' and do things differently than the large corporate consultancies dominating the industry: working openly and collaboratively with clients from start to finish, delivering outcomes based on innovative thinking, not methodology, and treating each client's business like their own. Elixirr was quoted on the AIM market of the London Stock Exchange in 2020 and listed on the Main Market of the London Stock Exchange in July 2025. In addition to strong organic growth, Elixirr has acquired seven boutique firms - Den Creative, Coast Digital, The Retearn Group, iOLAP, Responsum, Insigniam and Hypothesis - to grow the Group's capabilities, diversify the business, expand into new geographies and access new clients.

 

 

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.

RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
LISSDAFWSEISESM